Rokotetutkimuskeskus Finvac Oy

At Rokotetutkimuskeskus Finvac Oy in Kokkola, clinical research in respiratory tract diseases focuses on RSV prevention and protection for infants and children at higher risk of severe illness. These studies are aimed at evaluating how well new preventive approaches work and how safe and well tolerated they are.

• Prevention of RSV infection in infants and children at increased risk
• Testing the effectiveness of new RSV therapies and vaccines
• Assessing safety and tolerability in young participants

The site contributes to research on reducing RSV-associated lower respiratory disease and improving protection during the RSV season.

This clinic also supports studies in bacterial infections, especially pneumococcal disease, with a strong emphasis on prevention in young children. The research is designed to understand immune response and safety for candidate vaccines intended to help reduce infection risk.

• Studying pneumococcal infections in healthy toddlers
• Evaluating vaccine safety and immune response
• Supporting prevention of serious bacterial respiratory illness

These trials help build evidence for better protection against common childhood pneumococcal disease.

Research at this laboratory and testing facility includes broader work on virus diseases and how the immune system responds to preventive treatments. The main goal is to generate evidence on safety, immune response, and clinical benefit for new vaccines and antibody-based approaches.

• Exploring prevention of viral infections in infants and toddlers
• Measuring immune response to candidate vaccines
• Evaluating whether new preventive options reduce disease burden

The work reflects a clear focus on advancing infectious disease prevention through child-centered clinical research.